Abstract:N- Demethylsinomenine (NDSM), the in vivo demethylated metabolite of sinomenine, has exhibited antinociceptive efficacy against various pain models and may become a novel drug candidate for pain management. However, no reported analytical method for quantification of N- Demethylsinomenine in a biological matrix is currently available, and the pharmacokinetic properties of N- Demethylsinomenine are unknown. In the present study, an ultra-high performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS) method for quantification of N- Demethylsinomenine in rat plasma was developed and utilized to examine the preclinical pharmacokinetic profiles of N- Demethylsinomenine. The liquid-liquid extraction using ethyl acetate as the extractant was selected to treat rat plasma samples. The mixture of 25% aqueous phase (0.35% acetic acid-10 mM ammonium acetate buffer) and 75% organic phase (acetonitrile) was chosen as the mobile phases flowing on a ZORBAX C18 column to perform the chromatographic separation. After a 6-min rapid elution, NDSM and its internal standard (IS), metronidazole, were separated successfully. The ion pairs of 316/239 and 172/128 were captured for detecting N- Demethylsinomenine and IS, respectively, using multiple reaction monitoring (MRM) under a positive electrospray ionization (ESI) mode in this mass spectrometry analysis. The standard curve met linear requirements within the concentration range from 3 to 1000 ng/mL, and the lower limit of quantification (LLOQ) was 3 ng/mL. The method was evaluated regarding precision, accuracy, recovery, matrix effect, and stability, and all the results met the criteria presented in the guidelines for validation of biological analysis method. Then the pharmacokinetic profiles of N- Demethylsinomenine in rat plasma were characterized using this validated UPLC-MS/MS method. N- Demethylsinomenine exhibited the feature of linear pharmacokinetics after intravenous ( i.v. ) or intragastric ( i.g. ) administration in rats. After i. v. bolus at three dosage levels (0.5, 1, and 2 mg/kg), N- Demethylsinomenine showed the profiles of rapid elimination with mean half-life (T 1/2Z ) of 1.55–1.73 h, and extensive tissue distribution with volume of distribution (V Z ) of 5.62–8.07 L/kg. After i. g. administration at three dosage levels (10, 20, and 40 mg/kg), N- Demethylsinomenine showed the consistent peak time (T max ) of 3 h and the mean absolute bioavailability of N- Demethylsinomenine was 30.46%. These pharmacokinetics findings will aid in future drug development decisions of N- Demethylsinomenine as a potential candidate for pain analgesia.

Determination of Sinomenine in Human Plasma by HPLC/ESI/ion Trap Mass Spectrum

Determination of sinomenine in serum by thin-layer chromatography using solid phase extraction

High-performance Liquid Chromatography-tandem Mass Spectrometry for the Determination of the 21 Sulfonamide Residues in Eriocheir Sinensis

Determination of norepinephrine, dopamine and 5-hydroxytryptamine content in human serum by HPLC-MS/MS

Determination of Soyasaponins Ba and Bb in Human Serum by High-Performance Liquid Chromatography Coupled with Electrospray Ionization Tandem Mass Spectrometry

Concentration and Extraction of Sinomenine from Herb and Plasma Using a Molecularly Imprinted Polymer As the Stationary Phase

LC Determination and Pharmacokinetic Study of Sinomenine in Dog Plasma

Supercritical Fluid Extraction of Sinomenine from Sinomenium Acutum (thumb) Rehd Et Wils

Rapid Characterization of the Potential Active of Sinomenine in Rats by Ultra‐High‐Performance Liquid Chromatography‐Quadrupole‐Exactive Orbitrap Mass Spectrometry and Molecular Docking

Determination of a novel photosensitizer sinoporphyrin sodium in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry

Investigation of preclinical pharmacokinetics of N-demethylsinomenine, a potential novel analgesic candidate, using an UPLC-MS/MS quantification method

Discovery of chemical markers for improving the quality and safety control of Sinomenium acutum stem by the simultaneous determination of multiple alkaloids using UHPLC-QQQ-MS/MS

Determination of Sennoside A in Rat Plasma by Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry and Its Application to a Rat Pharmacokinetic Study

Determination of Sulbactam Sodium in Human Plasma by HPLC-MS/MS

Sensitive Quantification of Liensinine Alkaloid Using a HPLC-MS/MS Method and Its Application in Microvolume Rat Plasma

Determination of mycophenolic acid concentration in human plasma by high performance liquid chromatography with fluorescence detection

Simultaneous quantification of paeoniflorin, nobiletin, tangeretin, liquiritigenin, isoliquiritigenin, liquiritin and formononetin from Si-Ni-San extract in rat plasma and tissues by liquid chromatography-tandem mass spectrometry.

Determination of Pseudoephedrine in Human Plasma by HPLC-MS

DETERMINATION OF SILIBININ CONCENTRATION IN RAT PLASMA BY RP-HPLC

Rapid and Simultaneous Quantification of Polyamines in Human Plasma by LC–MS/MS After Pre-column Derivatization with N -(9-Fluorenylmethoxycarbonyloxy)succinimide

Identification and characterization of major alkaloid from Sinomenium acutum stem and their metabolites after oral administration in rat plasma, urine, bile and feces based on UPLC-Q-TOF/MS